Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Jun 30, 2018

Filed with the SEC on Aug 6, 2018 and accepted by EDGAR at Aug 6, 2018, 16:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-04-01 to 2018-06-30$4.0kus-gaap:Revenues
Revenue6 months2018-01-01 to 2018-06-30$9.0kus-gaap:Revenues
Research and development3 months2018-04-01 to 2018-06-30$14.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-01-01 to 2018-06-30$28.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2018-04-01 to 2018-06-30$13.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-01-01 to 2018-06-30$27.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-04-01 to 2018-06-30−$28.3mus-gaap:OperatingIncomeLoss
Operating income6 months2018-01-01 to 2018-06-30−$56.6mus-gaap:OperatingIncomeLoss
Income tax3 months2018-04-01 to 2018-06-30−$123.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-01-01 to 2018-06-30−$247.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-04-01 to 2018-06-30−$27.7mus-gaap:NetIncomeLoss
Net income6 months2018-01-01 to 2018-06-30−$55.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-04-01 to 2018-06-30−$0.35us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2018-01-01 to 2018-06-30−$0.70us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2018-01-01 to 2018-06-30−$31.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-01-01 to 2018-06-30$7.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2018-01-01 to 2018-06-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-06-30$16.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-06-30$110.1mus-gaap:AssetsCurrent
Total assetsAt period end2018-06-30$211.4mus-gaap:Assets
Current liabilitiesAt period end2018-06-30$20.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-06-30$29.8mus-gaap:Liabilities
Shareholders' equityAt period end2018-06-30$181.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-18-019420. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.